Induction of S100A9 gene expression by cytokine oncostatin M in breast cancer cells through the STAT3 signaling cascade

Breast Cancer Research and Treatment
Cong LiJingwen Liu

Abstract

Cytokine oncostatin M (OM) strongly inhibits the growth of MCF-7 breast cancer cells through the STAT3 signaling pathway. We have performed cDNA microarray analyses to identify novel OM-regulated genes in MCF-7 cells that are downstream effectors of the STAT3 signaling cascade. We show that expression of the calcium-binding protein S100A9 is strongly induced by OM in MCF-7 cells and this induction is markedly reduced in MCF-7-dnStat3 cells that express a dominant negative mutant of STAT3. We further show the induction of S100A9 by OM in other breast cancer cell lines whose proliferations are inhibited by OM whereas S100A9 is not significantly induced in SKBR-3 or HepG2 cells that do not respond to OM with a growth repression. In addition, inhibition of S100A9 expression with siRNA decreased cell response to OM-induced growth repression. By analyzing a series of S100A9 promoter reporter constructs, we have defined two discrete regions in the S100A9 promoter responsible for OM-induced transcriptional activation. Together these studies identify S100A9 as a novel OM-regulated gene through the STAT3-signaling cascade and suggest its involvement in the growth regulation of breast cancer cells.

References

Jan 1, 1990·Advances in Experimental Medicine and Biology·V van Heyningen, J Dorin
Nov 1, 1988·Trends in Biochemical Sciences·D Kligman, D C Hilt
Jan 1, 1995·Brain Research Bulletin·D B ZimmerW Song
Apr 1, 1996·Trends in Biochemical Sciences·B W Schäfer, C W Heizmann
Jan 5, 1999·The Journal of Experimental Medicine·N KiuchiT Hirano
Jul 31, 2002·The Journal of Biological Chemistry·Takaaki MatsuiAtsushi Miyajima

❮ Previous
Next ❯

Citations

Mar 3, 2007·Archives of Pharmacal Research·Hae-Young Yong, Aree Moon
Jul 28, 2012·Current Molecular Medicine·R DonatoC L Geczy
Jan 2, 2014·ISRN Inflammation·Carl D Richards
Nov 6, 2012·Biochimica Et Biophysica Acta·Joseph Markowitz, William E Carson
Apr 10, 2010·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Ioannis D KostakisAristidis Antsaklis
Oct 20, 2009·European Journal of Pharmacology·Saeid GhavamiClaus Kerkhoff
Feb 7, 2013·Scientific Reports·William R SwindellJohann E Gudjonsson
Aug 14, 2012·Experimental Dermatology·Claus KerkhoffKarin E Bornfeldt
Apr 17, 2012·International Journal of Cancer. Journal International Du Cancer·Sina GrebhardtDoris Mayer
Oct 16, 2013·Clinical Proteomics·Vinuth N PuttamalleshT S Keshava Prasad
Feb 25, 2009·Journal of Leukocyte Biology·Su Yin LimCarolyn L Geczy
Sep 13, 2008·The Journal of Biological Chemistry·Günther BodeWolfgang Nacken
Sep 24, 2020·American Journal of Physiology. Lung Cellular and Molecular Physiology·Christopher RailwahPatrick Geraghty
Jun 21, 2014·Molecular Cancer Research : MCR·Kiranmai GumireddyQihong Huang
Jul 10, 2021·Pulmonary Medicine·Zeeshan SattarPatrick Geraghty

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
K AraiR Nozawa
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Alexander HermaniDoris Mayer
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Julia NémethJochen Hess
© 2021 Meta ULC. All rights reserved